The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Those of us who conduct themselves with civility have as much as is needed, and none breaks any market rules. Whilst those of us who don't know how to conduct themselves with decency. Don't.
But what is the end game? Ian Ford has never shared his vision of what he wants the company to be. At the moment, the company still needs to raise funds to survive and it is possible that sufficient income will eventually bring profitability but then what? One of things I find most irksome about this forum is that nobody provides an analysis of likely scenarios. All we get is links to more products or dreamers plucking wild figures out of the air ranging from 5p to 22p. Now for once, without resorting to personal insults, can we have a sensible discussion on likely future growth which is based on best estimates because we'll never get a clue from the invisible man at the helm.
Only Debra at the weekends
:-)
Dreamer should have said
Another Debra per that hopes to buy below 0.50. Dream on. Another year gone on building towards the end game.
will check out latter Gixer.
Potential under Serybox umbrella-huge :)
After the placing , i wonder at what price i think 0.4p with all the progress they have achieved this year.....NOT.
Bodes well for any ff launch in China, which is about 30 x the population of S Korea
BBC radio 2 on about DVT and Covid this week:all about aspirin!!! Best unknown product;totally agree;have taken a position (again) will average down if placing comes before China(Hopefully!)
Did you read this?
https://www.fruitflowplus.com/COVID-19/
https://www.frontiersin.org/articles/10.3389/fnut.2020.583080/full
Cant say I know all the ins and outs but clinical trials of any significance cost money........
Lots of money.
But you are right, it would be good.
Hi Gixer,yes! i did think that...
but Aspirin (with potential known side effects-adding poss extra side issues to already otherwise weakened
immune systems)) are having a go.
Wouldnt it be prudent for ff (with no known side effects) to get on board?
Hi Tarka, the clue might be in the link you supplied as to why Fruitflow is not on a "Covid register"
As far as I am aware no clinical trials have been carried out on any benefits Fruitflow may have regarding Covid-19.
www.clinicaltrialsregister.eu
www.clinicaltrialregister.eu
Aspirin is on it!...proving its a blood thinning agent able to prevent covid patients blood
becoming sticky & thus potentially preventing neurological disability.....
Surely PXS should qualify to be on this register too (already proven ?)
As for who would want the IP?
3 possibilities maybe?
Not that I want to see it sold anytime soon.
everhopeful, he could only recommend what to do in a takeover situation but it would be down to a shareholder vote to decide.
Are you referring to the invisible man! Ford must be one of the most reclusive CEO's on AIM. He is not pictured anywhere and has never hosted a webcast or arranged a Q & A session as far as I am aware. He only seems to interact with his acolytes.
Why would they pay 5p when there is no competition ? who else wants PXS's IP ? Our useless CEO would take a TO at 2p imo.
5p is roughly 100m. Not a lot for the likes of by-health/DSM.
5p plus for me
I think most people would!
Cobalt,
I would bite your hand off at 2.2p!!!
Slam
My target is 22p.
PMSL . You'd need the biggest Chinese food / drink maker to put FF in several top sellers , not going to happen.
82k in 10 hours !!